Vitamin D and multiple sclerosis.

Vitamin D and multiple sclerosis.
复制标题

DOI:
10.1002/jcb.21858
复制
发表时间:
2008-10-01
影响因子:
4
通讯作者:
Christakes, Sylvia
Christakes, Sylvia
中科院分区:
生物学2区
文献类型:
--
作者:
Raghuwanshi, Anita;Joshi, Sneha S.;Christakes, Sylvia

文献摘要

参考文献

被引文献

相似文献

维生素D是钙稳态的主要调节剂。然而,最近的证据表明,维生素D还具有许多其他生理功能,包括抑制包括乳腺癌和前列腺癌在内的一些恶性肿瘤细胞的增殖,以及保护某些免疫介导性疾病,包括多发性硬化症(MS)。多发性硬化症的地理发病率表明,随着日光照射的减少,多发性硬化症的发生率增加。由于维生素D是通过太阳或紫外线辐射在皮肤中产生的,而且据报道,血清中高水平的25-羟基维生素D(25(OH)D)与降低患多发性硬化症的风险有关,因此建议维生素D具有保护作用。综述了维生素D的活性形式1,25-二羟基维生素D3(1,25(OH)2D3)介导这种保护作用的机制。由于其免疫抑制作用,有人认为1,25(OH)2D3可以阻止MS的诱导。
Vitamin D is a principal regulator of calcium homeostasis. However, recent evidence has indicated that vitamin D can have numerous other physiological functions including inhibition of proliferation of a number of malignant cells including breast and prostate cancer cells and protection against certain immune mediated disorders including multiple sclerosis (MS). The geographic incidence of MS indicates an increase in MS with a decrease in sunlight exposure. Since vitamin D is produced in the skin by solar or UV irradiation and high serum levels of 25-hydroxyvitamin D (25(OH)D) have been reported to correlate with a reduced risk of MS, a protective role of vitamin D is suggested. Mechanisms whereby the active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3 ) may act to mediate this protective effect are reviewed. Due to its immunosuppressive actions, it has been suggested that 1,25(OH)2D3 may prevent the induction of MS.
DOI: 10.1152/ajpendo.1983.244.3.e266
发表时间: 1983-01-01
影响因子: --
作者:
GASCONBARRE, M;HUET, PM
通讯作者: HUET, PM
DOI: 10.1080/00207237408709630
发表时间: 1974-01-01
影响因子: --
作者:
GOLDBERG, P
通讯作者: GOLDBERG, P
DOI: 10.1093/brain/123.5.968
发表时间: 2000-05-01
期刊: BRAIN
影响因子: 14.5
作者:
Hammond, SR;English, DR;McLeod, JG
通讯作者: McLeod, JG
DOI: 10.1093/jn/128.1.68
发表时间: 1998-01-01
影响因子: 4.2
作者:
Cantorna, MT;Hayes, CE;DeLuca, HF
通讯作者: DeLuca, HF
DOI: 10.1093/ajcn/61.3.638s
发表时间: 1995-03-01
影响因子: 7.1
作者:
HOLICK, MF
通讯作者: HOLICK, MF